AAPL $341.18 +0.94% ▲ ACN $239.24 +0.53% ▲ ADBE $256.26 +0.77% ▲ ADEA $21.80 +2.35% ▲ ADIG $16.30 +1.94% ▲ ADP $292.26 -0.17% ▼ ADSK $245.52 -0.05% ▼ AEHR $64.70 -1.67% ▼ AEVA $10.61 +1.43% ▲ AGYS $116.65 +0.20% ▲ AI $11.83 +1.11% ▲ AIP $20.27 -5.30% ▼ ALAB $285.90 -3.58% ▼ ALKT $15.06 +3.12% ▲ ALNT $95.85 +3.11% ▲ AMBA $64.04 -0.70% ▼ AMBQ $52.53 +1.06% ▲ AMD $543.95 -1.28% ▼ AMPL $15.88 +1.15% ▲ AMZN $260.19 -1.24% ▼ ANET $184.28 -0.89% ▼ AOSL $23.34 -0.89% ▼ APLD $20.38 +1.65% ▲ APP $269.91 -1.42% ▼ APPN $46.87 +1.89% ▲ APPS $10.10 +1.14% ▲ ARM $222.94 -2.22% ▼ ARRY $3.38 +0.45% ▲ ARW $218.67 +1.74% ▲ ASML $1,673.41 +0.25% ▲ AAPL $341.18 +0.94% ▲ ACN $239.24 +0.53% ▲ ADBE $256.26 +0.77% ▲ ADEA $21.80 +2.35% ▲ ADIG $16.30 +1.94% ▲ ADP $292.26 -0.17% ▼ ADSK $245.52 -0.05% ▼ AEHR $64.70 -1.67% ▼ AEVA $10.61 +1.43% ▲ AGYS $116.65 +0.20% ▲ AI $11.83 +1.11% ▲ AIP $20.27 -5.30% ▼ ALAB $285.90 -3.58% ▼ ALKT $15.06 +3.12% ▲ ALNT $95.85 +3.11% ▲ AMBA $64.04 -0.70% ▼ AMBQ $52.53 +1.06% ▲ AMD $543.95 -1.28% ▼ AMPL $15.88 +1.15% ▲ AMZN $260.19 -1.24% ▼ ANET $184.28 -0.89% ▼ AOSL $23.34 -0.89% ▼ APLD $20.38 +1.65% ▲ APP $269.91 -1.42% ▼ APPN $46.87 +1.89% ▲ APPS $10.10 +1.14% ▲ ARM $222.94 -2.22% ▼ ARRY $3.38 +0.45% ▲ ARW $218.67 +1.74% ▲ ASML $1,673.41 +0.25% ▲

MBody AI Enhances Orchestrator Platform with Multi-Robot Fleet Capabilities

July 16, 2026 · by TPW Pipeline

MBody AI Enhances Orchestrator Platform with Multi-Robot Fleet Capabilities

Check-Cap Ltd., through its merger partner MBody AI, has upgraded the capabilities of its proprietary robotics platform. The company announced that the MBody AI Orchestrator now features multi-robot fleet control, a development intended to expand the operational scope of its artificial intelligence-driven systems.

The MBody AI Orchestrator serves as the central operating system for the company’s robot fleet. By integrating multi-robot control, the platform aims to coordinate multiple units simultaneously, potentially increasing efficiency in complex environments. This advancement represents a technical expansion of the company’s software infrastructure, moving beyond single-unit management to broader fleet orchestration.

Check-Cap Ltd., currently classified within the healthcare diagnostics and research sector, is historically focused on capsule-based screening technology for the detection of precancerous colorectal polyps. The company is based in Isfiya, Israel. While the press release details the technological progress of MBody AI, Check-Cap’s stock performance reflected a downward trend during the current trading session.

Market Context

Shares of Check-Cap were trading lower by 3.81% today, with the price settling at $1.01 against a previous close of $1.05. The company holds a market capitalization of approximately $7.8 million.

What to watch

  • Future updates regarding the deployment status of the MBody AI Orchestrator.
  • Progress on the business combination between Check-Cap and MBody AI.
  • Regulatory filings or operational milestones related to the fleet management technology.

Source: original release